Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver hormone therapy, according to the results of a large clinical trial led by UCL ...

I f prostate cancer has spread to other areas of your body, your doctor may recommend androgen deprivation therapy (ADT), which halts the production of androgen hormones, especially testosterone.

Thousands of men with advanced prostate cancer could soon live longer thanks to a treatment which cuts the risk of the ...

Advanced prostate cancer is cancer that has spread beyond the prostate to distant parts of the body. It is also called metastatic or stage 4 prostate cancer. While most advanced prostate cancer is ...

Relugolix and degarelix are both effective in achieving and maintaining sustained castration in advanced prostate cancer. Relugolix’s oral form provides convenience, eliminating the need for frequent ...

Data from the PROTEUS trial showed that adding a hormone-blocking pill called apalutamide to standard hormone therapy, both ...

Credit: Getty Images The 2024 US Prostate Cancer Conference published 34 consensus recommendations addressing 5 main topic areas. Guidelines created by a multi-disciplinary panel of specialists focus ...

Experts project the diagnosis of over 300,000 prostate cancer cases in the United States in 2006, along with over 30,000 prostate cancer-related deaths. As such, prostate cancer remains the most ...

In a pooled analysis of the SPARTAN and TITAN trials, statin use during apalutamide therapy was associated with superior overall survival (OS) but also with an increased risk for grade 3 or greater ...

Researchers at Weill Cornell Medicine have led a phase 1 trial of a new drug that delivers potent radiation therapy directly and specifically to cancer cells in patients with advanced prostate cancer.

Doctors and scientists around the world are constantly searching for better ways to treat cancer. The goal is not only to help people live longer, but also to reduce side effects and improve quality ...

St Bartholomew's Hospital and The James Cook University Hospital mark key UK expansion of the company's Phase 2 mCRPC programme Dr Kenrick Ng, Medical Oncology Consultant, St Bartholomew's Hospital, ...